Stephen Pendergast/LinkedIn
Apr 22, 2026, 15:22
Stephen Pendergast: Are Universal Shelf Stable Blood Substitutes Finally Within Reach?
Stephen Pendergast, Consultant in Systems Engineering (Radar, Data Links, and Satellite Communications) and Senior Systems Engineer, shared a post on LinkedIn:
“Researchers at Japan’s Nara Medical University have engineered hemoglobin vesicles that work for blood transfusion replacements all blood types and last for years.
As clinical trials advance, parallel efforts in the U.S. and U.K. are converging on a long-elusive goal: a shelf-stable substitute for donated blood.
This could revolutionize emergency room and battlefield emergency care.”
Stay updated with Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice